PL2714647T3 - Pochodne bifenylu przydatne jako antagoniści receptora glukagonu - Google Patents

Pochodne bifenylu przydatne jako antagoniści receptora glukagonu

Info

Publication number
PL2714647T3
PL2714647T3 PL12724508T PL12724508T PL2714647T3 PL 2714647 T3 PL2714647 T3 PL 2714647T3 PL 12724508 T PL12724508 T PL 12724508T PL 12724508 T PL12724508 T PL 12724508T PL 2714647 T3 PL2714647 T3 PL 2714647T3
Authority
PL
Poland
Prior art keywords
receptor antagonists
glucagon receptor
derivatives useful
biphenyl derivatives
biphenyl
Prior art date
Application number
PL12724508T
Other languages
English (en)
Inventor
Devraj Chakravarty
Michael N Greco
Brian Shook
Guozhang Xu
Rui Zhang
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL2714647T3 publication Critical patent/PL2714647T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12724508T 2011-05-23 2012-05-23 Pochodne bifenylu przydatne jako antagoniści receptora glukagonu PL2714647T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161488848P 2011-05-23 2011-05-23
EP20120724508 EP2714647B1 (en) 2011-05-23 2012-05-23 Biphenyl derivatives useful as glucagon receptor antagonists
PCT/US2012/039173 WO2012162409A1 (en) 2011-05-23 2012-05-23 Biphenyl derivatives useful as glucagon receptor antagonists

Publications (1)

Publication Number Publication Date
PL2714647T3 true PL2714647T3 (pl) 2015-09-30

Family

ID=46178850

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12724508T PL2714647T3 (pl) 2011-05-23 2012-05-23 Pochodne bifenylu przydatne jako antagoniści receptora glukagonu

Country Status (12)

Country Link
US (1) US9045389B2 (pl)
EP (1) EP2714647B1 (pl)
JP (1) JP2014520093A (pl)
CN (1) CN103547563B (pl)
AU (1) AU2012258773A1 (pl)
CA (1) CA2837088A1 (pl)
DK (1) DK2714647T3 (pl)
ES (1) ES2544104T3 (pl)
MX (1) MX2013013732A (pl)
PL (1) PL2714647T3 (pl)
PT (1) PT2714647E (pl)
WO (1) WO2012162409A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10414434B2 (en) * 2017-04-03 2019-09-17 Robby Gordon Leading-edge steering assembly
CN116868999B (zh) * 2023-07-10 2025-08-22 山东大明消毒科技有限公司 一种二溴海因泡腾片及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739083A (en) 1995-10-13 1998-04-14 Otsuka Kagaku Kabushiki Kaisha Pyrazole derivatives and insecticidal compositions containing the derivative as active component
AU4537900A (en) * 1999-05-17 2000-12-05 Agouron Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
AU2002365622A1 (en) * 2001-12-03 2003-06-17 Novo Nordisk A/S Novel glucagon antagonists
WO2004056763A2 (en) * 2002-12-20 2004-07-08 Novo Nordisk A/S Novel glucagon antagonists
JP2007191461A (ja) * 2005-05-23 2007-08-02 Japan Tobacco Inc ピラゾール化合物及びそれらピラゾール化合物を含んでなる糖尿病治療薬
CN101291908A (zh) 2005-08-23 2008-10-22 Irm责任有限公司 免疫抑制剂化合物和组合物
ES2391109T3 (es) * 2005-11-17 2012-11-21 Eli Lilly And Company Antagonistas del receptor de glucagón, preparación y usos terapéuticos
WO2007111864A2 (en) 2006-03-23 2007-10-04 Merck & Co., Inc. Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
AR069802A1 (es) * 2007-12-20 2010-02-17 Astrazeneca Ab Compuestos de carbamoilo como inhibidores de dgat1 190
EP2714661B1 (en) 2011-05-23 2015-09-30 Janssen Pharmaceutica, N.V. Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists

Also Published As

Publication number Publication date
JP2014520093A (ja) 2014-08-21
CA2837088A1 (en) 2012-11-29
PT2714647E (pt) 2015-09-02
CN103547563A (zh) 2014-01-29
AU2012258773A1 (en) 2013-11-14
MX2013013732A (es) 2014-02-27
WO2012162409A1 (en) 2012-11-29
CN103547563B (zh) 2016-03-23
EP2714647A1 (en) 2014-04-09
DK2714647T3 (en) 2015-05-26
EP2714647B1 (en) 2015-04-29
US9045389B2 (en) 2015-06-02
US20120302641A1 (en) 2012-11-29
ES2544104T3 (es) 2015-08-27

Similar Documents

Publication Publication Date Title
IL233592A0 (en) p2x4 receptor antagonist
IL230061B (en) Glucagon/1–glp receptor co-agonists
ZA201400477B (en) Switch costimulatory receptors
IL229732A0 (en) Long-acting glucagon\1 -glp receptor agonists
PT2927224T (pt) Antagonistas de receptores
PL2714661T3 (pl) Pochodne kwasu pikolinamidopropanowego przydatne jako antagoniści receptora glukagonu
EP2665707A1 (en) Mineralocorticoid receptor antagonists
ZA201305576B (en) Trpm8 receptor antagonists
PL2928882T3 (pl) Pochodne pirazyny jako agoniści receptora cb2
IL232503A (en) H2 - Indazoles as antagonists of the ep2 receptor
ZA201404499B (en) Trpm8 antagonists
IL233485A0 (en) History of spiroindoline as gonadotropin-releasing hormone receptor antagonists
ZA201309100B (en) Heteroaryl compounds as 5-ht4 receptor ligands
EP2617717A4 (en) ANTAGONIST OF P2X4 RECEIVER
IL226920A (en) Pyrazole compounds as antagonists of crth2
IL235740A0 (en) Somatostatin receptor agonist formulations
IL231413A0 (en) Toll-like receptor 3 antagonists
ZA201301561B (en) 5-ht2b receptor antagonists
PT2714647E (pt) Derivativos bifenil usados como antagonistas do recetor da glicagina
GB201213699D0 (en) Receptor antagonists II
GB201213698D0 (en) Receptor antagonists II